R. Wenstrup

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Jing Wang, I. Wistuba, J. Fujimoto, 2022, British Journal of Cancer.

Edinburgh Research Explorer Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma

Edward S. Kim, I. Wistuba, R. Bueno, 2018 .

Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.

N. Schultz, H. Scher, D. Solit, 2022, European urology.

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Jing Wang, I. Wistuba, J. Fujimoto, 2022, British Journal of Cancer.

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

H. Beltran, J. Mosquera, Yipeng Wang, 2021, npj Precision Oncology.

PSMA-positive circulating tumor cell detection and outcomes with abiraterone or enzalutamide treatment in men with metastatic castrate resistant prostate cancer.

E. Antonarakis, A. Armstrong, D. Danila, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.

G. Di Caro, R. Wenstrup, Lee Schwartzberg, 2023, Journal of Clinical Oncology.

Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial.

E. Gonzalez-Billalabeitia, D. Wetterskog, A. Jayaram, 2024, European urology oncology.